Literature DB >> 29119224

Impact of repeated extracorporeal shock wave lithotripsy on prepubertal rat kidney.

Jae Min Chung1,2, Bu Kyung Park1, Jung Hee Kim2, Hyun Jung Lee3, Sang Don Lee4,5.   

Abstract

This study aimed to investigate the effects of repeated extracorporeal shock wave lithotripsy (ESWL) on the kidneys of prepubertal and adult rats. Thirty rats were used: 15 were prepubertal (3 weeks of age) with an average body weight of 72.3 ± 3.3 g, and 15 were adults with of 265 ± 11.3 g. The prepubertal and adult rats were separately and randomly allocated to three groups, each consisting of five rats. Following anesthetization, the left kidney of each rat in each group received shock waves in one, two, or three sessions separated by 72 h. The rats in each group were killed 72 h after the last ESWL session, and both kidneys were harvested; the right kidney was used as the control. Renal injury was examined with histological analysis, immunohistochemistry, and Western blot to detecting the expression of heat-shock protein-70, tumor necrosis factor-alpha-α, intercellular adhesion molecule-1, and monocyte chemoattractant protein-1 as markers of renal damage. All of these markers were similarly increased with increased ESWL sessions in both age groups. Histological analysis revealed more serious fibrosis and inflammation in the ESWL-treated kidneys in both groups than in the controls, with the damage increasing with increasing numbers of sessions. ESWL on the kidney increased renal damage according to the number of sessions in both age groups of rats, and the effects of ESWL on renal injury were similar in the two groups. However, there were generally no significant differences in the effects of ESWL on molecular indicators of renal injury between prepubertal and adult rats.

Entities:  

Keywords:  Adult; Inflammatory renal damage; Puberty; Shock wave

Mesh:

Substances:

Year:  2017        PMID: 29119224     DOI: 10.1007/s00240-017-1011-0

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   3.436


  30 in total

1.  Short-term changes in renal function after extracorporeal shock wave lithotripsy in children.

Authors:  K K Villányi; J G Székely; L M Farkas; C Pusztai
Journal:  J Urol       Date:  2001-07       Impact factor: 7.450

2.  Effects of extracorporeal shockwave lithotripsy on renal growth and function: an animal model.

Authors:  J de A Claro; F Denardi; U Ferreira; N Rodrigues Netto; L B Saldanha; J F Figueiredo
Journal:  J Endourol       Date:  1994-06       Impact factor: 2.942

3.  Diabetes mellitus and hypertension associated with shock wave lithotripsy of renal and proximal ureteral stones at 19 years of followup.

Authors:  Amy E Krambeck; Matthew T Gettman; Audrey L Rohlinger; Christine M Lohse; David E Patterson; Joseph W Segura
Journal:  J Urol       Date:  2006-05       Impact factor: 7.450

4.  The effects of extracorporeal shock wave lithotripsy on antioxidant enzymes in erythrocytes.

Authors:  Yilmaz Aksoy; Ismail Malkoc; Ali Fuat Atmaca; Hülya Aksoy; Konca Altinkaynak; Fatih Akcay
Journal:  Cell Biochem Funct       Date:  2006 Sep-Oct       Impact factor: 3.685

Review 5.  Experimental basis of shockwave-induced renal trauma in the model of the canine kidney.

Authors:  J Rassweiler; K U Köhrmann; W Back; S Fröhner; M Raab; A Weber; F Kahmann; E Marlinghaus; K P Jünemann; P Alken
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

6.  Antisense oligonucleotides for ICAM-1 attenuate reperfusion injury and renal failure in the rat.

Authors:  H Haller; D Dragun; A Miethke; J K Park; A Weis; A Lippoldt; V Gross; F C Luft
Journal:  Kidney Int       Date:  1996-08       Impact factor: 10.612

7.  Alterations in predicted growth rates of pediatric kidneys treated with extracorporeal shockwave lithotripsy.

Authors:  D A Lifshitz; J E Lingeman; F S Zafar; D W Hollensbe; A W Nyhuis; A P Evan
Journal:  J Endourol       Date:  1998-10       Impact factor: 2.942

Review 8.  Monocyte chemoattractant protein-1: a key mediator in inflammatory processes.

Authors:  Esther Melgarejo; Miguel Angel Medina; Francisca Sánchez-Jiménez; José Luis Urdiales
Journal:  Int J Biochem Cell Biol       Date:  2008-08-08       Impact factor: 5.085

9.  Cryptococcal capsular glucuronoxylomannan reduces ischaemia-related neutrophil influx.

Authors:  P M Ellerbroek; R G Schoemaker; R van Veghel; A I M Hoepelman; F E J Coenjaerts
Journal:  Eur J Clin Invest       Date:  2004-09       Impact factor: 4.686

10.  Effect of extracorporeal shock wave lithotripsy on renal function and body height in pediatric patients.

Authors:  R Thomas; J M Frentz; E Harmon; G D Frentz
Journal:  J Urol       Date:  1992-09       Impact factor: 7.450

View more
  4 in total

1.  Tissue neutrophil elastase contributes to extracorporeal shock wave lithotripsy-induced kidney damage and the neutrophil elastase inhibitor, sivelestat, attenuates kidney damage with gratifying immunohistopathological and biochemical findings: an experimental study.

Authors:  Aykut Colakerol; Serhat Suzan; Mustafa Zafer Temiz; Serkan Gonultas; Serdar Aykan; Sule Ozsoy; Suat Hayri Kucuk; Emrah Yuruk; Engin Kandırali; Atilla Semercioz
Journal:  Urolithiasis       Date:  2021-11-15       Impact factor: 3.436

2.  The clinical and immunological features of the post-extracorporeal shock wave lithotripsy anti-glomerular basement membrane disease.

Authors:  Beining Wang; Jia Xiaoyu; Xiaojuan Yu; Zhao Cui; Minghui Zhao
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

3.  Efficacy of Super-Mini-PCNL and Ureteroscopy in Kidney Stone Sufferers and Risk Factors of Postoperative Infection.

Authors:  Wenbing Yuan; Yingyi Li; Yu Dai; Cheng Luo; Hui Zhang; Haijun Xiong
Journal:  J Healthc Eng       Date:  2022-03-08       Impact factor: 2.682

4.  The Antidiabetic and Antinephritic Activities of Tuber melanosporum via Modulation of Nrf2-Mediated Oxidative Stress in the db/db Mouse.

Authors:  Xue Jiang; Shanshan Teng; Xue Wang; Shan Li; Yaqin Zhang; Di Wang
Journal:  Oxid Med Cell Longev       Date:  2018-07-29       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.